SAPN-Nucleic Acid Delivery Platform
Infectious Diseases, Oncology (mRNA/DNA vaccines, immunotherapies)
Pre-clinicalPlatform Development
Key Facts
Indication
Infectious Diseases, Oncology (mRNA/DNA vaccines, immunotherapies)
Phase
Pre-clinical
Status
Platform Development
Company
About Alpha-O Peptides
Alpha-O Peptides AG is a private Swiss biotech firm specializing in the development of advanced vaccine and drug delivery platforms centered on Self-Assembling Protein Nanoparticles (SAPN). The company has built a robust patent estate with filings in major global markets, protecting its core technologies for antigen display, vaccine applications, and immunostimulatory delivery. Its business model revolves around technology development and out-licensing to pharmaceutical and biotechnology partners for further clinical development and commercialization.
View full company profile